Loading...
Bimatoprost Implant: First Approval
Bimatoprost implant (Durysta™), developed by Allergan, is a sustained-release drug delivery system containing bimatoprost, a prostaglandin analogue with ocular hypotensive activity. The implant, administered intracamerally, involves the use of a biodegradable, solid polymer drug delivery system for...
Na minha lista:
| Udgivet i: | Drugs Aging |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7303088/ https://ncbi.nlm.nih.gov/pubmed/32447639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-020-00769-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|